Glide Pharma Adds $21.4M
Oxford, England-based Glide Pharma raised $21.4 million in new funding. The company, a pharmaceutical development and device company, is backed by investors including Invesco Perpetual. Glide Pharma will use the funds for manufacturing of its solid dose injector system.
26 February 2013•3 mins read
